⌘K

Login Start Free

Home/Filings/4/0000897069-24-001862

4//SEC Filing

Neal James R 4

Accession 0000897069-24-001862

CIK 0001533743other

View on SEC.gov Company Profile

Filed

Sep 17, 8:00 PM ET

Accepted

Sep 18, 4:48 PM ET

Size

5.1 KB

Accession

0000897069-24-001862

Insider Transaction Report

Form 4

Period: 2024-09-03

Processa Pharmaceuticals, Inc.PCSA

Director

Transactions

Award
Restricted Stock
2024-09-03+31,206→ 31,206 total
Exercise: $0.00→ Common Stock (31,206 underlying)

Footnotes (1)

[F1]The restricted stock vest on the earlier of June 28, 2025 or the next annual meeting of stockholders, subject to certain distribution requirements.

Documents

1 file

4
form4.xmlPrimary

Issuer

Processa Pharmaceuticals, Inc.

CIK 0001533743

Entity typeother

Related Parties

1

filerCIK 0001600865

Filing Metadata

Form type: 4
Filed: Sep 17, 8:00 PM ET
Accepted: Sep 18, 4:48 PM ET
Size: 5.1 KB

View on SEC.gov